The panel discuss the key points that emerged from the first day of the 10^th iwNHL meeting in Boston. Topics include the role of antigenic drive of B-cells in different lymphomas, the prospect of curative therapies for front line diffuse large B-cell lymphoma, potential new therapies to target B-cell receptor signalling pathways and treatment options for T-cell lymphoma.

In addition, the panel discuss a number of concerns that have emerged. These include the need for additional research clarifying the value of maintenance therapies, uncertainty of the biology and mechanism of action of new CNS treatments and concerns over the choice of patients for clinical trials